Enlivex Therapeutics
ENLV
ENLV
20 hedge funds and large institutions have $8.38M invested in Enlivex Therapeutics in 2021 Q3 according to their latest regulatory filings, with 5 funds opening new positions, 5 increasing their positions, 5 reducing their positions, and 5 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
20
Holders Change
–
Holders Change %
0%
% of All Funds
0.35%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
5
Increased
5
Reduced
5
Closed
5
Calls
$1.65M
Puts
$1.4M
Net Calls
+$253K
Net Calls Change
+$1.38M
Top Buyers
1 |
State Street
Boston,
Massachusetts
|
+$183K |
2 |
VF
Virtu Financial
New York
|
+$171K |
3 |
Geode Capital Management
Boston,
Massachusetts
|
+$102K |
4 |
CLOS
Compagnie Lombard Odier SCmA
1204 Geneva,
Switzerland
|
+$101K |
5 |
Morgan Stanley
New York
|
+$43.8K |